Analyst
BMO
Equibles does not estimate personal net worth.
Evan is recorded as Analyst at BMO. Evan has spoken on 2 earnings calls across 2 companies, most recently for Albemarle Corp on August 6, 2026. Those appearances were for Albemarle Corp (ALB) and AbCellera Biologics Inc. (ABCL). The companies whose calls Evan spoke on are classified in the Basic Materials and Healthcare sectors.
“Your cash buildup has been quite large recently and some of your peers have announced restarts and project go-aheads. When would we expect you to go ahead with some of your brownfield projects or shorter of that, how does the company want to use your extra cash?”
“I want to ask how to think about partner-initiated programs in the clinic. These look somewhat stagnant since 2024, and to be clear, we appreciate the conversion to more Abcelro-led development, but just wanted to understand why these partner-initiated programs may not be progressing clinically.”
BMO
Analyst
Transcript header (unverified)
ALB
Specialty Chemicals · Basic Materials
